ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Programs: Advisory Panel Formed On Cancer and Alternative Medicine

July 16, 1999

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008

In Brief: Brandt Names To Health Position; Everett Koop Would Be Surgeon General In HHS Reorganization

February 20, 1981

NCI Spearheads Asbestos Alert

June 16, 1978

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

October 25, 2013

NCI says SELECT study is close to full enrollment.

April 23, 2004